Uncategorized
Inotek posts $6.6 million quarterly loss
Inotek Pharmaceuticals reported a net loss of $6.6 million in the second quarter of 2017 compared with a net loss of $8.7 million in the second quarter of 2016. Research and development costs decreased from $6.5 million in 2016’s second quarter to $3.6 million in 2017, according to a company press release. General and administrative expenses decreased by $100,000 to $2.2 million in the quarter.